investorscraft@gmail.com

Intrinsic ValueNorthWest Healthcare Properties Real Estate Investment Trust (NWH-UN.TO)

Previous Close$5.15
Intrinsic Value
Upside potential
Previous Close
$5.15

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

NorthWest Healthcare Properties REIT operates as a specialized real estate investment trust focused on high-quality healthcare infrastructure across Canada, Brazil, Europe, Australia, and New Zealand. Its portfolio includes medical office buildings, clinics, and hospitals, characterized by long-term, inflation-indexed leases with stable occupancy rates. The REIT serves as a strategic real estate partner to leading healthcare operators, leveraging its fully integrated management team across nine offices in five countries to optimize asset performance and tenant relationships. NorthWest's diversified geographic footprint and focus on essential healthcare real estate provide resilience against economic cycles, while its emphasis on long-duration leases ensures predictable cash flows. The REIT's competitive advantage lies in its deep sector expertise, international scale, and ability to align with healthcare operators' needs, positioning it as a key player in the global healthcare real estate market.

Revenue Profitability And Efficiency

NorthWest reported revenue of CAD 462.4 million for the period, reflecting its stable lease-based income model. However, the REIT posted a net loss of CAD 299.8 million, with diluted EPS of -CAD 1.21, indicating significant financial pressures. Operating cash flow stood at CAD 86.6 million, while capital expenditures were minimal at CAD -0.9 million, suggesting a focus on maintaining rather than expanding its current asset base.

Earnings Power And Capital Efficiency

The REIT's negative earnings highlight challenges in its current operational and financial structure. With a market capitalization of CAD 1.17 billion and a beta of 1.216, NorthWest exhibits higher volatility than the broader market. The modest operating cash flow relative to its debt load raises questions about its ability to service obligations while maintaining dividend payouts.

Balance Sheet And Financial Health

NorthWest's balance sheet shows CAD 51.2 million in cash against total debt of CAD 3.01 billion, indicating a highly leveraged position. This substantial debt burden, coupled with recent net losses, may constrain financial flexibility. The REIT's asset-heavy model provides collateral but also requires careful management of refinancing risks and interest rate exposure.

Growth Trends And Dividend Policy

Despite financial challenges, NorthWest maintains a dividend yield with CAD 0.36 per share distributed. The REIT's growth prospects depend on its ability to stabilize earnings, manage debt, and potentially capitalize on global healthcare real estate demand. Its international diversification could provide opportunities, but current financial performance suggests a cautious approach to expansion.

Valuation And Market Expectations

The market values NorthWest at approximately 2.5 times revenue, reflecting both the stability of healthcare real estate and concerns about its profitability. Investors appear to be pricing in expectations for operational improvements and potential asset sales to address the REIT's financial challenges while maintaining its income-oriented appeal.

Strategic Advantages And Outlook

NorthWest's strategic advantages include its specialized healthcare focus, international diversification, and long-term lease structure. However, its outlook depends on improving operational efficiency, reducing leverage, and navigating global real estate market conditions. The essential nature of healthcare real estate provides a defensive position, but execution risks remain elevated given current financial pressures.

Sources

Company description, financial data from TSX filings

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount